NCT04846231
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Cleveland Clinic Cleveland, Ohio, United States
Clinical trial condition
Hypercholesterolemia
Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.
955 public trials
47 recruiting studies
Hypercholesterolemia trial results
NCT05460364
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +7 more
- Locations
-
- Inha University Hospital Incheon, South Korea
NCT05858372
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- Skylitseio General Hospital Chios, Greece
Completed
Oil Consumption and Cholesterol
NCT04397055
- Conditions
- Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
- Locations
-
- University of Georgia Athens, Georgia, United States
NCT03510884
- Conditions
- Dyslipidemias, Hypercholesterolaemia, Hypercholesterolemia, +4 more
- Locations
-
- Excel Medical Clinical Trials, LLC-Site Number:8400001 Boca Raton, Florida, United States
- Washington University School of Medicine-Site Number:8400006 St Louis, Missouri, United States
- Presbyterian Novant Heart & Wellness-Site Number:8400002 Charlotte, North Carolina, United States
- Cincinnati Children's Hospital Medical Center-Site Number:8400005 Cincinnati, Ohio, United States
NCT00107744
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +6 more
- Locations
-
Not specified
NCT02867813
- Conditions
- Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Research Site Birmingham, Alabama, United States
- Research Site Huntsville, Alabama, United States
- Research Site Phoenix, Arizona, United States
- Research Site Banning, California, United States
NCT02178098
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +6 more
- Locations
-
- Birmingham, Alabama, United States
- Muscle Shoals, Alabama, United States
- Chandler, Arizona, United States
- Glendale, Arizona, United States
Completed
Trial to Evaluate Efficacy and Safety of LIB003, Evolocumab and Alirocumab in High-risk CVD Patients
NCT04790513
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypercholesterolemia, +4 more
- Locations
-
- Sterling Research Group Cincinnati, Ohio, United States
- The Lindner Research Center Cincinnati, Ohio, United States
- Metabolic & Atherosclerosis Research Center (MARC) Cincinnati, Ohio, United States
NCT03084822
- Conditions
- Behavior, Body Weight, Cardiovascular Diseases, +28 more
- Locations
-
Not specified